Aspen Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Aspen Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,372	Closed	-$209K	–	148
2021 Q4	$209K	Sell	1,372 -1,239	-47%	-$192K	0.1%	138
2021 Q3	$422K	Buy	2,611 +1,158	+80%	+$195K	0.22%	100
2021 Q2	$238K	Hold	1,453	–	–	0.12%	140
2021 Q1	$219K	Sell	1,453 -30	-2%	-$4.76K	0.12%	140
2020 Q4	$225K	Sell	1,483 -20	-1%	-$2.86K	0.13%	127
2020 Q3	$204K	Sell	1,503 -20	-1%	-$2.71K	0.14%	120
2020 Q2	$208K	Buy	+1,523	New	+$194K	0.15%	112
2019 Q4	–	Sell	-7,629	Closed	-$759K	–	133
2019 Q3	$759K	Sell	7,629 -219	-3%	-$22.9K	0.51%	69
2019 Q2	$856K	Sell	7,848 -229	-3%	-$24.4K	0.56%	59
2019 Q1	$903K	Hold	8,077	–	–	0.63%	55
2018 Q4	$779K	Sell	8,077 -377	-4%	-$40K	0.62%	52
2018 Q3	$1.03M	Sell	8,454 -199	-2%	-$23.4K	0.68%	44
2018 Q2	$950K	Buy	8,653 +462	+6%	+$49.4K	0.66%	46
2018 Q1	$874K	Buy	8,191 +1,048	+15%	+$116K	0.63%	50
2017 Q4	$763K	Buy	7,143 +936	+15%	+$100K	0.54%	58
2017 Q3	$690K	Buy	6,207 +72	+1%	+$7.7K	0.51%	59
2017 Q2	$634K	Sell	6,135 -321	-5%	-$31.6K	0.48%	60
2017 Q1	$631K	Buy	6,456 +45	+0.7%	+$4.31K	0.47%	57
2016 Q4	$567K	Buy	+6,411	New	+$583K	0.43%	58

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aspen Investment Management's IBB Position: Q1 2022 in Review

Aspen Investment Management sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,372 shares — an estimated $209K sold.

Aspen Investment Management first reported a position in IBB in Q4 2016 and held it in 19 quarters. The position peaked at $1.03M in Q3 2018. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Aspen Investment Management reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Aspen Investment Management sold 1,372 iShares Biotechnology ETF shares in Q1 2022, an estimated $209K.
Aspen Investment Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 19 quarters.
Aspen Investment Management's iShares Biotechnology ETF position peaked at $1.03M in Q3 2018.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Aspen Investment Management's 13F filing for Q1 2022, filed 11 May 2022.